Open AccessNovel management of critically induced polyneuropathy in intensive care patients: A case report of two patients
Author(s) -
Vanita Ahuja,
Selwin Rajan Selvam,
Anjuman Chander,
Nishit Sawal
Publication year - 2021
Publication title -
journal of anaesthesiology-clinical pharmacology/journal of anaesthesiology clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.466
H-Index - 32
eISSN - 2231-2730
pISSN - 0970-9185
DOI - 10.4103/joacp.joacp_427_19
Subject(s) - medicine , intensive care unit , intensive care medicine , weakness , pyridostigmine , intensive care , critically ill , polyneuropathy , critical illness polyneuropathy , supportive psychotherapy , critical illness , surgery , myasthenia gravis
There has been tremendous growth in patients requiring critical care with severe infections. During a prolonged stay in the intensive care unit (ICU), patients develop critical illness polyneuropathy (CIP). The early identification of neurological involvement requires special attention during ICU care. We describe two cases who developed complete motor weakness after a prolonged stay in ICU. Patients were successfully managed with pyridostigmine and testosterone hormonal therapy initially and later with pyridostigmine only. The present case series highlights the need for early recognition, assessment, and novel management of CIP in ICU patients. However, the role of nutrition, physiotherapy, and supportive care is equally essential for the successful outcome in these patients.